Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) During Pregnancy

Sponsor
Penn State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05822531
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
20
1
10

Study Details

Study Description

Brief Summary

This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Maternal CVH Intervention
N/A

Detailed Description

The Promoting Cardiovascular Health of Northern Appalachian Women During and After Pregnancy:

Pilot Study is a single arm pilot study that will enroll pregnant women (<28 weeks' gestation) participating in the NFP home visitation program in the Northern Appalachian region of Central Pennsylvania. This pilot study will include an enhanced version of the NFP standard care plan delivered by trained nurses to promote cardiovascular health among women by targeting decreased sedentary time and enhanced physical activity (and where applicable smoking cessation) during and after pregnancy. This pilot study will also examine the feasibility and acceptability of digital devices (actigraphy, digital scale, blood pressure monitor) during this same time period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This pilot study is being conducted to inform feasibility of the next phase of this research project.This pilot study is being conducted to inform feasibility of the next phase of this research project.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Promoting Cardiovascular Health of Northern Appalachian Women During and After Pregnancy: PSU Maternal Pilot Study
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Maternal Cardiovascular health (CVH) Intervention

The pilot maternal CVH intervention will be delivered by NFP partners starting as early as NFP program enrollment in the first trimester after confirmation of a viable pregnancy and no later than the 28th week of pregnancy and will continue up to 6 months postpartum. The visit schedule will be consistent with the NFP visit structure to deliver intervention content at regularly scheduled visits that are typically 60 minutes long (weekly visits for the first month following enrollment followed by twice monthly visits until delivery). The pilot study will include an enhanced behavioral component target decreased sedentary time and increase physical activity and utilizing a technology/monitoring component. All women be monitored using a wrist-worn actigraphy device to record daily activity, intermittent home blood pressure self-monitoring, intermittent home weight self-monitoring, and carbon monoxide monitoring administered by the NFP nurse.

Behavioral: Maternal CVH Intervention
All participants will be enrolled into the intervention arm of this pilot study.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of integrating a cardiovascular health module to the existing Nurse-Family Partnership (NFP) home visiting program. [6 months]

    Feasibility will be determined good acceptability by NFP nurses as assessed qualitatively during group discussions.

Secondary Outcome Measures

  1. Feasibility and acceptability of using a wrist-worn actigraphy device to record daily activity during and after pregnancy as measured by days with complete actigraphy data. [6 months]

    Determined successful uptake and demonstrable utility of device as measured by days with complete data.

  2. Feasibility and acceptability of using a digital scale for intermittent home self-monitoring of body weight during and after pregnancy as measured by days with recorded body weight. [6 months]

    Determined successful uptake and demonstrable utility of device as measured by days with complete data of body weight.

  3. Feasibility and acceptability of using a monitor for intermittent home self-monitoring of blood pressure during and after pregnancy as measured by days of recorded data. [6 months]

    Determined successful uptake and demonstrable utility of device as demonstrated by days with complete data.

  4. Feasibility and acceptability using a carbon monoxide monitor to assess baseline carbon monoxide levels with continued monitoring of elevated levels as measured by days with recorded measurements. [6 months]

    Determined successful uptake and demonstrable utility of device as measured by participants with completed assessments.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Nulliparous pregnant woman

  2. Age ≥ 18 years old

  3. Enrolled in and receiving the Nurse-Family Partnership program through the Geisinger Clinic or UPMC Home Health Care of Central PA

  4. English speaking

  5. Women with a singleton viable pregnancy confirmed by NFP home visitors

  6. Access to reliable internet service required for data collection

  7. A minimum of 5 women with use of nicotine containing products (cigarette, cigar, hookah, chewing tobacco, e-cigarette, patch) within the past 3 months

Exclusion Criteria:
  1. Unable or unwilling to comply with the study visits and procedures

  2. Participation in a concurrent interventional study

  3. Diagnosis of cancer

  4. A personal history of complex congenital heart disease

  5. A fetus in the current pregnancy with known chromosomal abnormalities or birth defects inconsistent with survival to 2 years will be excluded

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Penn State University
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Ian M Paul, MD, MSc, Penn State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ian M. Paul, M.D., M.Sc., Professor of Pediatrics and Public Health Sciences; Chief, Division of Academic General Pediatrics; Vice Chair of Faculty Affairs, Department of Pediatrics Affiliation: Penn State University, Penn State University
ClinicalTrials.gov Identifier:
NCT05822531
Other Study ID Numbers:
  • STUDY00021577
  • 1UG3HL162971-01
First Posted:
Apr 20, 2023
Last Update Posted:
Apr 20, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2023